Continue to meet or exceed healthcare partners’ expectations by providing on-time test results approximately 92 percent of the time.
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
CTS merges with the three Red Cross testing laboratories located in Charlotte, Portland and St. Loui...